Have a feature idea you'd love to see implemented?
Let us know!
Price (delayed)
$390.14
Market cap
$148.73B
P/E Ratio
41.37
Dividend/share
$3.2
EPS
$9.43
Enterprise value
$160.36B
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems;
Highlights
SYK's quick ratio has soared by 57% YoY and by 36% from the previous quarter
SYK's net income is up by 39% year-on-year and by 4.1% since the previous quarter
SYK's P/E is 9% above its last 4 quarters average of 38.0 but 3.6% below its 5-year quarterly average of 42.9
SYK's debt is up by 27% from the previous quarter and by 22% YoY
Key stats
What are the main financial stats of SYK
Market
Valuations
Earnings
Shares outstanding
381.22M
Market cap
$148.73B
Enterprise value
$160.36B
Price to earnings (P/E)
41.37
Price to book (P/B)
7.38
Price to sales (P/S)
6.77
EV/EBIT
38.27
EV/EBITDA
34.79
EV/Sales
7.3
Revenue
$21.97B
EBIT
$4.19B
EBITDA
$4.61B
Free cash flow
$3.21B
Per share
Balance sheet
Liquidity
EPS
$9.43
Free cash flow per share
$8.41
Book value per share
$52.87
Revenue per share
$57.66
TBVPS
$59.03
Total assets
$43.83B
Total liabilities
$23.68B
Debt
$15.48B
Equity
$20.15B
Working capital
$7B
Debt to equity
0.77
Current ratio
1.91
Quick ratio
1.1
Net debt/EBITDA
2.52
Margins
Efficiency
Dividend
EBITDA margin
21%
Gross margin
63.6%
Net margin
16.3%
Operating margin
19.9%
Return on assets
8.8%
Return on equity
18.5%
Return on invested capital
17.7%
Return on capital employed
11.6%
Return on sales
19.1%
Dividend yield
0.82%
DPS
$3.2
Payout ratio
33.9%
SYK stock price
How has the Stryker stock price performed over time
Intraday
1.16%
1 week
1.79%
1 month
6.23%
1 year
32.85%
YTD
30.28%
QTD
7.99%
Financial performance
How have Stryker's revenue and profit performed over time
Revenue
$21.97B
Gross profit
$13.97B
Operating income
$4.37B
Net income
$3.59B
Gross margin
63.6%
Net margin
16.3%
SYK's net income is up by 39% year-on-year and by 4.1% since the previous quarter
The operating income has grown by 27% year-on-year and by 3.7% since the previous quarter
SYK's net margin is up by 25% YoY
Stryker's operating margin has increased by 15% YoY
Growth
What is Stryker's growth rate over time
Valuation
What is Stryker stock price valuation
P/E
41.37
P/B
7.38
P/S
6.77
EV/EBIT
38.27
EV/EBITDA
34.79
EV/Sales
7.3
Stryker's EPS has increased by 38% YoY and by 4% from the previous quarter
SYK's P/E is 9% above its last 4 quarters average of 38.0 but 3.6% below its 5-year quarterly average of 42.9
SYK's P/B is 19% above its 5-year quarterly average of 6.2 and 10% above its last 4 quarters average of 6.7
SYK's equity is up by 13% year-on-year
The stock's price to sales (P/S) is 23% more than its 5-year quarterly average of 5.5 and 11% more than its last 4 quarters average of 6.1
The company's revenue rose by 11% YoY and by 2.7% QoQ
Efficiency
How efficient is Stryker business performance
The ROA has grown by 28% YoY
The ROE rose by 23% YoY
Stryker's ROIC has increased by 22% YoY
Stryker's ROS has increased by 19% YoY
Dividends
What is SYK's dividend history
DPS
$3.2
Dividend yield
0.82%
Payout ratio
33.9%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Stryker financials performed over time
The total assets is 85% greater than the total liabilities
SYK's quick ratio has soared by 57% YoY and by 36% from the previous quarter
The current ratio has grown by 29% year-on-year and by 14% since the previous quarter
SYK's debt is 23% less than its equity
SYK's debt is up by 27% from the previous quarter and by 22% YoY
The debt to equity has grown by 24% from the previous quarter and by 8% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.